Method of providing aripiprazole to patients having impaired CYP2D6 or CYP3A4 enzyme function

摘要

The disclosed embodiments relate to methods of initiating aripiprazole treatment in a patient who is a CYP2D6 poor metabolizer or a CYP3A4 poor metabolizer, or both.